Literature DB >> 24474694

An immunogenic peptide in the A-box of HMGB1 protein reverses apoptosis-induced tolerance through RAGE receptor.

Philippe M LeBlanc1, Teresa Ann Doggett, Jayoung Choi, Mark A Hancock, Yves Durocher, Filipp Frank, Bhushan Nagar, Thomas A Ferguson, Maya Saleh.   

Abstract

Apoptotic cells trigger immune tolerance in engulfing phagocytes. This poorly understood process is believed to contribute to the severe immunosuppression and increased susceptibility to nosocomial infections observed in critically ill sepsis patients. Extracellular high mobility group box 1 (HMGB1) is an important mediator of both sepsis lethality and the induction of immune tolerance by apoptotic cells. We have found that HMGB1 is sensitive to processing by caspase-1, resulting in the production of a fragment within its N-terminal DNA-binding domain (the A-box) that signals through the receptor for advanced glycation end products (RAGE) to reverse apoptosis-induced tolerance. In a two-hit mouse model of sepsis, we show that tolerance to a secondary infection and its associated mortality were effectively reversed by active immunization with dendritic cells treated with HMGB1 or the A-box fragment, but not a noncleavable form of HMGB1. These findings represent a novel link between caspase-1 and HMGB1, with potential therapeutic implications in infectious and inflammatory diseases.

Entities:  

Keywords:  Apoptosis; Caspase; Inflammation; Innate Immunity; Receptor for Advanced Glycation End Products (RAGE); Sepsis; Tolerance

Mesh:

Substances:

Year:  2014        PMID: 24474694      PMCID: PMC3953289          DOI: 10.1074/jbc.M113.541474

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock.

Authors:  Wei Shao; Garabet Yeretssian; Karine Doiron; Sabah N Hussain; Maya Saleh
Journal:  J Biol Chem       Date:  2007-10-24       Impact factor: 5.157

2.  Bim siRNA decreases lymphocyte apoptosis and improves survival in sepsis.

Authors:  Steven J Schwulst; Jared T Muenzer; Octavia M Peck-Palmer; Katherine C Chang; Christopher G Davis; Jacquelyn S McDonough; Dale F Osborne; Andrew H Walton; Jacqueline Unsinger; Jonathan E McDunn; Richard S Hotchkiss
Journal:  Shock       Date:  2008-08       Impact factor: 3.454

3.  The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.

Authors:  Hulda Sigridur Hreggvidsdottir; Therese Ostberg; Heidi Wähämaa; Hanna Schierbeck; Ann-Charlotte Aveberger; Lena Klevenvall; Karin Palmblad; Lars Ottosson; Ulf Andersson; Helena Erlandsson Harris
Journal:  J Leukoc Biol       Date:  2009-06-29       Impact factor: 4.962

4.  High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes.

Authors:  Ju Ho Youn; Young Joo Oh; Eun Sook Kim; Ji Eun Choi; Jeon-Soo Shin
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

5.  Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes.

Authors:  Takashi Ito; Ko-ichi Kawahara; Kohji Okamoto; Shingo Yamada; Minetsugu Yasuda; Hitoshi Imaizumi; Yuko Nawa; Xiaojie Meng; Binita Shrestha; Teruto Hashiguchi; Ikuro Maruyama
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-03       Impact factor: 8.311

6.  HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products.

Authors:  Yang-Hua Qin; Sheng-Ming Dai; Gu-Sheng Tang; Jun Zhang; Ding Ren; Zhi-Wei Wang; Qian Shen
Journal:  J Immunol       Date:  2009-11-15       Impact factor: 5.422

Review 7.  Binding of S100 proteins to RAGE: an update.

Authors:  Estelle Leclerc; Günter Fritz; Stefan W Vetter; Claus W Heizmann
Journal:  Biochim Biophys Acta       Date:  2008-12-11

8.  Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein.

Authors:  Hirotaka Kazama; Jean-Ehrland Ricci; John M Herndon; George Hoppe; Douglas R Green; Thomas A Ferguson
Journal:  Immunity       Date:  2008-07-18       Impact factor: 31.745

9.  Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis.

Authors:  James L Wynn; Philip O Scumpia; Matthew J Delano; Kerri A O'Malley; Ricardo Ungaro; Amer Abouhamze; Lyle L Moldawer
Journal:  Shock       Date:  2007-12       Impact factor: 3.454

10.  Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines.

Authors:  Luca Cassetta; Orazio Fortunato; Leda Adduce; Chiara Rizzi; Julia Hering; Patrizia Rovere-Querini; Marco Emilio Bianchi; Massimo Alfano; Guido Poli
Journal:  AIDS       Date:  2009-03-13       Impact factor: 4.177

View more
  28 in total

1.  Downregulation of high mobility group protein box-1 resensitizes ovarian cancer cells to carboplatin.

Authors:  Wen Shu
Journal:  Oncol Lett       Date:  2018-07-30       Impact factor: 2.967

2.  Extracellular HMGB1 regulates multi-walled carbon nanotube-induced inflammation in vivo.

Authors:  Forrest Jessop; Andrij Holian
Journal:  Nanotoxicology       Date:  2014-07-01       Impact factor: 5.913

Review 3.  Location is the key to function: HMGB1 in sepsis and trauma-induced inflammation.

Authors:  Meihong Deng; Melanie J Scott; Jie Fan; Timothy R Billiar
Journal:  J Leukoc Biol       Date:  2019-04-04       Impact factor: 4.962

4.  The expression of HMGB1 on microparticles from Jurkat and HL-60 cells undergoing apoptosis in vitro.

Authors:  D M Spencer; F Mobarrez; H Wallén; D S Pisetsky
Journal:  Scand J Immunol       Date:  2014-08       Impact factor: 3.487

5.  RAGE-NF-κB-PPARγ Signaling is Involved in AGEs-Induced Upregulation of Amyloid-β Influx Transport in an In Vitro BBB Model.

Authors:  Fang Chen; Arijit Ghosh; Mei Hu; Yan Long; Hongbin Sun; Lingyi Kong; Hao Hong; Susu Tang
Journal:  Neurotox Res       Date:  2017-09-04       Impact factor: 3.911

6.  Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro.

Authors:  Fu-Cai Wang; Jing-Xuan Pei; Jun Zhu; Nan-Jin Zhou; Dong-Sheng Liu; Hui-Fang Xiong; Xiao-Qun Liu; Dong-Jia Lin; Yong Xie
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

7.  Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice.

Authors:  Konstantin Stark; Vanessa Philippi; Sven Stockhausen; Johanna Busse; Antonella Antonelli; Meike Miller; Irene Schubert; Parandis Hoseinpour; Sue Chandraratne; Marie-Luise von Brühl; Florian Gaertner; Michael Lorenz; Alessandra Agresti; Raffaele Coletti; Daniel J Antoine; Ralf Heermann; Kirsten Jung; Sven Reese; Iina Laitinen; Markus Schwaiger; Axel Walch; Markus Sperandio; Peter P Nawroth; Christoph Reinhardt; Sven Jäckel; Marco E Bianchi; Steffen Massberg
Journal:  Blood       Date:  2016-08-29       Impact factor: 22.113

8.  Frontline Science: HMGB1 induces neutrophil dysfunction in experimental sepsis and in patients who survive septic shock.

Authors:  Murielle Grégoire; Jean-Marc Tadié; Fabrice Uhel; Arnaud Gacouin; Caroline Piau; Nathaniel Bone; Yves Le Tulzo; Edward Abraham; Karin Tarte; Jaroslaw W Zmijewski
Journal:  J Leukoc Biol       Date:  2016-12-13       Impact factor: 4.962

Review 9.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 10.  High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule.

Authors:  Huan Yang; Haichao Wang; Sangeeta S Chavan; Ulf Andersson
Journal:  Mol Med       Date:  2015-10-27       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.